Drug Database
NA

naproxen (naproxen, Verex / naproxen, Biovail)

✓ Approved

Bausch Health Companies Inc. · PTGS1 · 小分子

什么是 naproxen?

naproxen 是一种小分子,由Bausch Health Companies Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名naproxen, Verex, naproxen, Biovail
公司Bausch Health Companies Inc.
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

naproxen 作用于 2 个分子靶点:

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

naproxen 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersMusculoskeletal pain✓ Approved

相关研究文献

PubMedLife sciences2026-11-18

Candidate molecular mechanisms of naproxen hepatotoxicity: an evidence-graded narrative review of bioactivation, mitochondrial dysfunction, and immune-mediated liver injury.

Siddiqui Shakir S, William Neha Ronald NR

Naproxen sodium, a propionic acid-derived non-steroidal anti-inflammatory drug (NSAID) introduced in 1976, has a favorable hepatic safety profile. Yet clinically apparent naproxen-induced liver injury (NILI) occurs rarely (~1-3 per 100,000 exposed patients), ranging from transient transaminase elevation to cholestatic hepatitis with ductopenia and, exceptionally, acute liver failure. Unlike diclofenac, naproxen lacks mechanistic synthesis. This review aimed to integrate and grade evidence for candidate mechanisms of naproxen hepatotoxicity. Molecular, biochemical, immunological, and clinical data were synthesized in a narrative review. Each candidate mechanism was graded using explicit criteria distinguishing naproxen-specific findings from mechanisms extrapolated from other NSAIDs or hepatotoxicants. Naproxen-specific evidence is strongest for hepatic bioactivation to a reactive acyl-β-D-glucuronide and a coenzyme-A thioester forming covalent protein adducts (isolated rat liver), ex vivo memory T-cell responses to an oxidative desmethyl-naproxen metabolite in a few patients, and rodent oxidative-stress and aminotransferase changes. Cyclooxygenase-dependent loss of hepatoprotection, mitochondrial permeability transition, ATP depletion, Keap1-Nrf2-ARE signaling, HLA-restricted sensitization, Kupffer-cell amplification, and BSEP/MRP2 interference are extrapolated or hypothetical for naproxen, and no study links these steps within one naproxen system. Convergence on intrinsic mitochondrial apoptosis is untested. Clinically, naproxen carries lower liver risk than diclofenac despite overlapping mechanistic potential. This synthesis separates evidence-based from speculative mechanisms of naproxen hepatotoxicity, supporting causality assessment and prioritizing human-relevant experiments for mechanistic and pharmacovigilance research. Hepatoprotective and pharmacogenomic strategies are hypothesis-generating, not clinical recommendations. Only 4 of 12 graded nodes are naproxen-specific; the rest are hypotheses, not an established causal cascade.

PMID 43051448
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Self-Reporting Fluorescent Prodrug for Esterase-Guided Drug Release and Inflammation-Triggered Bioimaging.

R A Aswini A, Karmakar Abhijit A, Katiyar Astha A, Koner Apurba Lal AL

Stimuli-responsive prodrugs that combine therapeutic efficacy with optical reporting offer promising avenues for precision medicine. This study presents a dicyanoisophorone-naproxen (DCIP-Nap) conjugate, which merges the anti-inflammatory effects of naproxen with a donor-π-acceptor fluorescent scaffold. Initially, the conjugate is nonfluorescent due to suppressed intramolecular charge transfer. However, it shows a notable fluorescence "turn-on" response upon ester bond cleavage, facilitated by serum albumin. This selective release of active naproxen also restores the ICT process, resulting in a red-shifted emission. The probe further exhibits selective responsiveness toward peroxynitrite (ONOO-), a reactive nitrogen species abundantly generated in inflamed cells. Confocal microscopy using human glioblastoma (U-87 MG) and human leukemia monocytic (THP-1) cells demonstrated increased fluorescence intensity under inflammatory conditions, confirming ONOO--mediated drug release. In vivo studies in LPS-treated mice showed fluorescence activation and decreased pro-inflammatory cytokines (TNF-α and IL-6), highlighting the therapeutic potential of DCIP-Nap. This study positions DCIP-Nap as an innovative fluorescent prodrug for targeted therapy and real-time monitoring in complex diseases.

PMID 43046396
阅读全文 →
PubMedPoultry science2026-11-18

The crystal structures of avian serum albumin from domesticated birds.

Duszynski Kajetan K, Bujacz Anna A, Pietrzyk-Brzezinska Agnieszka J AJ, Bujacz Grzegorz G

Serum albumins, the most abundant proteins in blood plasma, are the main carriers of physiological and exogenous ligands in the circulatory systems of all vertebrates. Their sequence and structure strongly correlate with vertebrate evolution. Until now, only crystal structures of serum albumin from a few mammal species have been determined, with human serum albumin (HSA) being the most extensively studied. We present here the first crystal structures of avian serum albumins (ASA) from domestic poultry, chicken (ChSA), turkey (TSA), and duck (DSA), in their native form and in complexes with selected pharmaceuticals. ChSA crystals were obtained in two space groups, P212121 (1.76 Å) and C2221 (2.36 Å), whereas TSA (1.70 Å) and DSA (1.78 Å) crystallized in the same C2 space group. In this work, we compare the avian serum albumin structures with the known crystal structures of mammalian serum albumins, including HSA, pointing to the evolution of this protein, and its properties to bind antibiotic - cefaclor and a non-steroidal anti-inflammatory drug - naproxen.

PMID 43050946
阅读全文 →
PubMedFrontiers in chemistry2026-11-17

Validated RP-HPLC method for simultaneous determination of doxorubicin and 5F: application in nanoliposome formulation development and pharmacokinetic studies.

Duan Zhihong Z, Zheng Chao C, Yu Zelin Z, Fu Hongbo H et al.

The study aims to develop a reversed-phase high-performance liquidchromatography (RP-HPLC) method for the simultaneous determination of two antitumor drugs, doxorubicin (DOX) and ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid (5F), in KM mice plasma following intravenous administration. Nanoliposomes co-loaded with DOX and 5F were prepared using thin-film hydration method and administered intravenously to KM mice. Liquid-liquid extraction with methanol as the extraction solvent was employed to isolate DOX and 5F from plasma samples prior to Chromatographic analysis. Chromatographic separation of DOX and 5F was performed on an Agilent 1,260 series HPLC system fitted with Hypersil ODS C18 column. The mobile phase consisted of methanol/1% glacial acetic acid (40:60, v/v) at a flow rate of 1.0 mL min-1. Detection wavelength was set at 242 nm and the column temperature was maintained at 30 °C ± 2 °C. Naproxen was selected as standard (IS). To assess matrix effect and specificity, blank liposome formulation spiked with DOX and 5F was disrupted with methanol and analyzed by HPLC; meanwhile, matrix effect in plasma was evaluated using six individual blank plasma samples with post-extraction spiking at three QC concentration levels (0.125, 0.25 and 0.5 μg mL-1) for both analytes. The method was validated strictly in accordance with ICH guidelines. The linear ranges of DOX and 5F were 0.125-2.0 μg mL-1 and 0.0625-0.6 μg mL-1, respectively. Both analytes achieved favorable linearity with correlation coefficients greater than 0.998. Recoveries from quality control samples were 84.2%-85.5% for DOX and 86.2%-87.1% for 5F. The intra-day and inter-day precisions were less than 10% for all QC samples. The limits of quantitation (LOQ) were 60 ng mL-1 for DOX and 20 ng mL-1 for 5F. Matrix effect of DOX and 5F in blank liposome formulation and plasma exerted no significant influence on the separation and detection of DOX and 5F under the established RP-HPLC conditions. The developed HPLC method exhibited satisfactory precision, accuracy and acceptable limits of quantitation. The validated assay was proven suitable for the pharmacokinetic studies of DOX and 5F in mice.

PMID 43041473
阅读全文 →
PubMedToxicology reports2026-11-16

Refractory circulatory shock following intentional polypharmacy antihypertensive and NSAID overdose: Clinical recovery temporally associated with sequential intravenous lipid emulsion and methylene blue - A case report.

Danial Syed Hussain SH, Honan David Michael DM

Calcium channel blocker (CCB) overdose carries substantial mortality without advanced organ support. Ingestion of a fixed-dose antihypertensive combination with a non-steroidal anti-inflammatory drug (NSAID) is an uncommon polypharmacy toxidrome. The role of intravenous lipid emulsion (ILE) and methylene blue in refractory cases remains poorly defined. A 64-year-old man (135 kg) ingested approximately 300 mg amlodipine, 300 mg perindopril, 75 mg indapamide and 15,000 mg naproxen with ethanol. Despite apparent stability on arrival he deteriorated to 77/47 mmHg, pH 7.20 and lactate 10.5 mmol/L. Seven hours of escalating treatment - noradrenaline (peak 58 mcg/min), vasopressin, calcium and high-dose insulin euglycaemic therapy (HIET) - failed to restore haemodynamic targets. Intralipid 20% was given (total approximately 8.9 mL/kg), followed 35 min later by methylene blue 140 mg (1.0 mg/kg). Lactate fell from 10.5 to 6.1 mmol/L over the subsequent 55 min with the noradrenaline dose unchanged. All vasopressors were stopped within 14 h. HIET was accompanied by concurrent glucose, potassium and phosphate nadirs (1.7, 1.7 and 0.27 mmol/L). KDIGO stage 2 acute kidney injury (peak creatinine 303 µmol/L) required no renal replacement therapy and resolved completely (creatinine 81 µmol/L at 3.5 months). The patient was discharged on day 9. Sequential ILE and methylene blue were temporally associated with rapid metabolic recovery in refractory circulatory shock following polypharmacy antihypertensive overdose. Individual contributions cannot be determined from a single case, and a delayed effect of concurrent HIET cannot be excluded. These agents may represent rescue options when conventional therapy is insufficient.

PMID 43036329
阅读全文 →
PubMedACS materials Au2026-11-15

Thermodynamic Eigenrate Decomposition for Drug Release from Electrospun Fibrous Matrices: Plain-Polymer, Cyclodextrin-Complexed, and Experimentally Informed Formulations.

Supaphol Pitt P

Diffusion, swelling, and erosion act on different time scales in electrospun matrices, making release hard to predict based on formulation variables. The Modified Multicomponent Interactive Release (M-MIR) model assigns each mechanism a first-order depletion rate in reciprocal seconds, so that the three become commensurable and their normalized ratios serve as mechanistic weights. These follow from Hansen solubility parameters, Flory-Huggins interaction parameters and partition coefficients, and are settled before any release datum is consulted. A Flory-Rehner criterion switches the swelling pathway off for non-swelling polymers, a mass-balance-constrained burst term completes the early-time description, and a two-scale analysis identifies the mat half-thickness, not the fiber radius, as the rate-controlling diffusion length. Three tiers cover plain matrices, cyclodextrin inclusion complexes, and systems where measured swelling and mass-loss functions replace the constitutive sub-models. The model is tested on two published systems lying on opposite sides of the swelling criterion. For naproxen in poly-(ε-caprolactone) (PCL) nanofibers, plain and β-cyclodextrin (CD)-inclusion complexed (IC), an interaction parameter of 9.75 from tabulated data alone closes the gate, fixing the diffusion weight at unity with nothing adjusted; the description ranks first for the plain formulation and resolves complexation into a 65% fall in effective diffusivity opposed by a 2.45-fold rise in the fitted transport constant, which a single empirical rate cannot separate. For ciprofloxacin and rutin released together from crosslinked poly-(vinyl alcohol) (PVA)/chitosan membranes, the gate is open, with the weights being swelling-dominated at 0.58 to 0.69, and the description ranks first on all three profiles. The two tests are not equivalent: the closed gate is predicted from tabulated data, whereas the open gate is established from measured swelling and corroborated against independent determinations, with the solubility-parameter route being unreliable for water-rich media. Throughout, the fitted burst fraction orders correctly with solubility and composition, and every parameter remains non-negative and mechanistically readable, which the closest classical competitor does not achieve. The framework reduces to the classical release equations as limiting cases.

PMID 43032567
阅读全文 →

注册免费账户还可查看另外 7581 篇文献

免费注册查看全部文献 →

了解更多naproxen